candesartan has been researched along with Glomerulonephritis in 7 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Glomerulonephritis: Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Japanese patients with renal insufficiency were randomly assigned to receive either an ACE inhibitor (benazepril 1." | 5.12 | A five-year comparison of the renal protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with non-diabetic nephropathy. ( Kanno, Y; Shoda, J; Suzuki, H, 2006) |
| "Candesartan promotes a complementary antiproteinuric and a small antihypertensive effect after a treatment period of 8 weeks in patients with chronic glomerulonephritis when given in conjunction with an ACEI." | 5.10 | Reduction of proteinuria; combined effects of receptor blockade and low dose angiotensin-converting enzyme inhibition. ( Bader, BD; Berger, ED; Ebert, C; Erley, CM; Risler, T, 2002) |
| "The antifibrotic substance pirfenidone and the angiotensin II type I receptor antagonist candesartan cilexetil, given alone and in combination, were tested in rats with chronic anti-glomerular basement membrane glomerulonephritis (anti-GBM GN)." | 3.73 | Pirfenidone and candesartan ameliorate morphological damage in mild chronic anti-GBM nephritis in rats. ( Forslund, T; Iversen, BM; Leh, S; Margolin, SB; Vaagnes, Ø, 2005) |
| "5-year prospective study compared the effects of angiotensin II receptor blocker, candesartan(n = 21), and ACE inhibitor(ACEI, n = 23) on proteinuria and renal function in patients with moderate renal impairment due to chronic glomerulonephritis." | 3.71 | [Comparison of ARB and ACEI for renoprotection in chronic glomerulonephritis]. ( Iigaya, K; Imai, M; Kumagai, H; Matsuura, T; Onami, T; Sakata, K; Saruta, T, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumagai, H | 1 |
| Sakata, K | 1 |
| Matsuura, T | 1 |
| Imai, M | 1 |
| Onami, T | 1 |
| Iigaya, K | 1 |
| Saruta, T | 1 |
| Hollenberg, NK | 1 |
| Leh, S | 1 |
| Vaagnes, Ø | 1 |
| Margolin, SB | 1 |
| Iversen, BM | 1 |
| Forslund, T | 1 |
| Chang, A | 1 |
| Logar, CM | 1 |
| Finn, LS | 1 |
| Alpers, CE | 1 |
| Seliger, SL | 1 |
| Shoda, J | 1 |
| Kanno, Y | 1 |
| Suzuki, H | 1 |
| Kurokawa, K | 1 |
| Berger, ED | 1 |
| Bader, BD | 1 |
| Ebert, C | 1 |
| Risler, T | 1 |
| Erley, CM | 1 |
3 trials available for candesartan and Glomerulonephritis
| Article | Year |
|---|---|
Reduction of proteinuria; combined effects of receptor blockade and low dose angiotensin-converting enzyme inhibition.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; | 2003 |
A five-year comparison of the renal protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with non-diabetic nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Ben | 2006 |
Reduction of proteinuria; combined effects of receptor blockade and low dose angiotensin-converting enzyme inhibition.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihyperte | 2002 |
4 other studies available for candesartan and Glomerulonephritis
| Article | Year |
|---|---|
[Comparison of ARB and ACEI for renoprotection in chronic glomerulonephritis].
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl | 2002 |
Pirfenidone and candesartan ameliorate morphological damage in mild chronic anti-GBM nephritis in rats.
Topics: Analysis of Variance; Animals; Antibodies; Autoantibodies; Base Sequence; Benzimidazoles; Biopsy, Ne | 2005 |
A rare cause of necrotizing and crescentic glomerulonephritis in a young adult male.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Autoa | 2005 |
Effects of candesartan on the proteinuria of chronic glomerulonephritis.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Arterioles; Benzimidazoles; | 1999 |